Skip to main content
Clinical Trials/NCT01416922
NCT01416922UnknownNot Applicable

The oncoFISH Cervical Test for Detection of 3q26 Region Gain

Ikonisys, Inc.1 site in 1 country1,100 target enrollmentStarted: June 2009Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Enrollment
1,100
Locations
1

Study Overview

Brief Summary

The purpose of this study is to evaluate the use of the oncoFISH cervical test system in the management of women who have received an LSIL Pap report to determine whether the test can predict which women will progress to more serious cervical disease and which women do not have to be monitored as closely.

Study Design

Study Type
Observational
Observational Model
Cohort
Time Perspective
Prospective

Eligibility Criteria

Ages
21 Years to — (Adult, Older Adult)
Sex
Female
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • Women 21 years of age or greater with recent LSIL who are scheduled for colposcipal assessment.
  • Women with previous or current STD or HIV may be included
  • Women with previous LSIL history may be included.

Exclusion Criteria

  • pregnant women,
  • women with vaginal intraepithelial lesions,
  • women on a chemotherapeutic agent,
  • women with previous or current cancer except for non-cervical squamous cell carcinoma

Investigators

Sponsor Class
Industry

Study Sites (1)

Loading locations...

Similar Trials